Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine for Levodopa-Induced Dyskinesia in PD
NCT01937078Phase 2Completed
- Sponsor
- University Health Network
- Start
- Apr 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of famotidine in levodopa-induced dyskinesia (LID), sponsored by University Health Network. Started Apr 2011; status: completed.
02
Drugs
famotidine
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT01937078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01937078.